1Hardy K J,Lipton J,Scase MQ,et al.Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas.Br J Ophthalmol,1992,76:461-464.
2Palmowski AM,Sutter EE,Bearse MA,et al.Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram.Invest Ophthalmol Vis Sci,1997,38:2586-2596.
3Dosso A,Bonvin A,Morel ER,et al.Risk factors associated with contrast sensitivity loss in diabetic patients.Graefe's Arch Clin Exp Ophthalmol,1996,234:300-305.
4Reber F,Geffarth R,Kasper M,et al.Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advance glycosylation end products and ways of protection.Graefe's Arch Clin Exp Ophthalmol,2003,241:213-225.
5徐淑云.药理实验方法学（第2版）[M].北京:人民卫生出版社,1991.180-191.
6Honjo M,Tanihara H,Kido N,et al.Expression of ciliary neurotrophic factor activated by retinal Müller cells in eyes with NMDA-and kainic acid-induced neuronal death.Invest Ophthalmol Vis Sci,2000,41:552-560.
8Hadjadj-S,Pean F, Gallois Y, etal. Different patterns of insulin resistance in relative of type 1 diabetic patients with retinopathy or nephropathy: the genesis france-belgium study [ J]. Diabetes Care, 2004, 27 ( 11 ) :2661-2668.
9Treins C, Giorgetti-peraloli S, Murdaca J, et al. Regulation of vascular endothelial growth factor expression by advanced glycation end products [ J]. J Biol Chem, 2001,276(47) :43836-43841.
10Moore TC, Moore JE, Kaji Y, et al. The role of advanced glycation end products in retinal microvascular leukostasis[J]. Invest Ophthalmol Vis Sci, 2003,44(10) :4457-4464.
